Clinical Management of Recurrent Breast Cancer: Development of Multidrug Resistance (MDR) and Strategies to Circumvent it

This publication has 28 references indexed in Scilit:

• The Role of ABC Transporters in Clinical Practice
  The Oncologist, 2003
• Involvement of phosphatidylinositol-3-kinase in membrane ruffling induced by P-glycoprotein substrates in multidrug-resistant carcinoma cells
  Biochemical Pharmacology, 2002
• Multidrug resistance in cancer: role of ATP–dependent transporters
  Nature Reviews Cancer, 2002
• Treatment of Multidrug Resistant (MDR1) Murine Leukemia with P-Glycoprotein Substrates Accelerates the Course of the Disease
  Biochemical and Biophysical Research Communications, 1999
• Multidrug Resistance in Breast Cancer: a Meta-analysis of MDR1/gp170 Expression and Its Possible Functional Significance
  JNCI: Journal of the National Cancer Institute, 1997
• Trifluoperazine as a modulator of multidrug resistance in refractory breast cancer
  Cancer Chemotherapy and Pharmacology, 1996
• P-Glycoprotein-Mediated Multidrug Resistance: Experimental and Clinical Strategies for its Reversal
  1996
• Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents.
  Journal of Clinical Investigation, 1993
• Cyclosporine treatment of refractory T-cell lymphomas
  Cancer, 1993
• Terfenadine (seldane®): A new drug for restoring sensitivity to multidrug resistant cancer cells
  Biochemical Pharmacology, 1993